{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:49:12Z","timestamp":1774435752293,"version":"3.50.1"},"reference-count":197,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.arbres.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T11:18:51Z","timestamp":1642418331000},"page":"323-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Biomarcadores biol\u00f3gicos en las enfermedades respiratorias"],"prefix":"10.1016","volume":"58","author":[{"given":"Francisco","family":"Garc\u00eda-R\u00edo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardino","family":"Alc\u00e1zar-Navarrete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Castillo-Villegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catia","family":"Cilloniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Garc\u00eda-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Leiro-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Lojo-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Padilla-Galo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Quezada-Loaiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Antonio","family":"Rodriguez-Portal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"S\u00e1nchez-de-la-Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriol","family":"Sibila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2022.01.003_bib0990","doi-asserted-by":"crossref","first-page":"343fs10","DOI":"10.1126\/scitranslmed.aaf8590","article-title":"Measure for Measure: Biomarker standards and transparency","volume":"8","author":"FitzGerald","year":"2016","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib0995","series-title":"BEST (Biomarkers Endpoints, and other Tools) Resource [Internet]","year":"2016"},{"key":"10.1016\/j.arbres.2022.01.003_bib1000","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.autrev.2016.06.005","article-title":"Personalized medicine Closing the gap between knowledge and clinical practice","volume":"15","author":"Anaya","year":"2016","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.arbres.2022.01.003_bib1005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp Biol Med (Maywood)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1010","doi-asserted-by":"crossref","first-page":"9.23.1","DOI":"10.1002\/cpph.19","article-title":"Biomarkers-A General Review","volume":"76","author":"Aronson","year":"2017","journal-title":"Curr Protoc Pharmacol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1015","first-page":"149","article-title":"Genetic tests and genomic biomarkers: regulation, qualification and validation","volume":"5","author":"Novelli","year":"2008","journal-title":"Clin Cases Miner Bone Metab."},{"key":"10.1016\/j.arbres.2022.01.003_bib1020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2001-1326-3-7","article-title":"Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development","volume":"3","author":"Frantzi","year":"2014","journal-title":"Clin Transl Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/metabo8040059","article-title":"A Framework for Development of Useful Metabolomic Biomarkers and Their Effective Knowledge Translation","volume":"8","author":"Marchand","year":"2018","journal-title":"Metabolites."},{"issue":"7\u20138","key":"10.1016\/j.arbres.2022.01.003_bib1030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/10408363.2017.1410520","article-title":"Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory","volume":"54","author":"Garc\u00eda-Gim\u00e9nez","year":"2017","journal-title":"Crit Rev Clin Lab Sci."},{"key":"10.1016\/j.arbres.2022.01.003_bib1035","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.2017.11295","article-title":"Digital Phenotyping: Technology for a New Science of Behavior","volume":"318","author":"Insel","year":"2017","journal-title":"JAMA."},{"key":"10.1016\/j.arbres.2022.01.003_bib1040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arbres.2020.07.024","article-title":"Prevalence and Determinants of COPD in Spain: EPISCAN II","volume":"57","author":"Soriano","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/thoraxjnl-2018-211855","article-title":"Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis","volume":"74","author":"Fermont","year":"2019","journal-title":"Thorax."},{"key":"10.1016\/j.arbres.2022.01.003_bib1050","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1001\/jama.2013.5732","article-title":"Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease","volume":"309","author":"Thomsen","year":"2013","journal-title":"JAMA."},{"key":"10.1016\/j.arbres.2022.01.003_bib1055","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1164\/rccm.201305-0892OC","article-title":"Club cell protein 16 and disease progression in chronic obstructive pulmonary disease","volume":"188","author":"Park","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2213-2600(15)00196-4","article-title":"Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: A prospective study","volume":"3","author":"Guerra","year":"2015","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1065","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1164\/rccm.201810-1860SO","article-title":"Chronic obstructive pulmonary disease biomarkers and their interpretation","volume":"199","author":"Stockley","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1070","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1080\/07853890.2021.1949489","article-title":"Variability of blood eosinophil count and prognosis of COPD exacerbations","volume":"53","author":"Mart\u00ednez-Gestoso","year":"2021","journal-title":"Ann Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1075","article-title":"miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary Disease","volume":"S0300\u20132896","author":"Matamala","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1080","first-page":"00016","article-title":"Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients","volume":"S0300\u20132896","author":"Garc\u00eda-Valero","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1085","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.arbr.2019.10.019","article-title":"Hypermethylation of Anti-oncogenic MicroRNA 7 is Increased in Emphysema Patients","volume":"56","author":"Rosas-Alonso","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12931-019-1268-7","article-title":"Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis","volume":"21","author":"Harries","year":"2020","journal-title":"Respir Res."},{"key":"10.1016\/j.arbres.2022.01.003_bib1100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.arbres.2019.12.015","article-title":"Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study","volume":"57","author":"Miravitlles","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.arbres.2019.09.015","article-title":"Plasma Eosinophil Count and Patient-Centered Events in Chronic Obstructive Pulmonary Disease in Real-Life Clinical Practice","volume":"56","author":"Golpe","year":"2020","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.arbres.2019.09.015","article-title":"Plasma Eosinophil Count and Patient-Centered Events in Chronic Obstructive Pulmonary Disease in Real-Life Clinical Practice","volume":"56","author":"Golpe","year":"2020","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.arbres.2019.08.023","article-title":"Clinical Characteristics and Risk of Exacerbations Associated With Different Diagnostic Criteria of Asthma-COPD Overlap","volume":"56","author":"Soler-Catalu\u00f1a","year":"2020","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1120","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.arbres.2019.09.002","article-title":"Medicina personalizada en la enfermedad pulmonar obstructiva cr\u00f3nica: \u00bfc\u00f3mo de cerca estamos?","volume":"56","author":"D\u00edaz L\u00f3pez","year":"2020","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.arbres.2020.08.002","article-title":"GesEPOC 2021: One More Step Towards Personalized Treatment of COPD","volume":"57","author":"Miravitlles","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arbr.2020.10.010","article-title":"Highlights of the Spanish Asthma Guidelines (GEMA), version 5.0","volume":"57","author":"Plaza","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MCP.0000000000000010","article-title":"Biomarker sampling of the airways in asthma","volume":"20","author":"Alexis","year":"2014","journal-title":"Curr Opin Pulm Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1975","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/all.13806","article-title":"Toward clinically applicable biomarkers for asthma: An EAACI position paper","volume":"74","author":"Diamant","year":"2019","journal-title":"Allergy."},{"key":"10.1016\/j.arbres.2022.01.003_bib1140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arbres.2020.01.018","article-title":"Might basophils be a reliable biomarker in severe asthma?","volume":"57","author":"Garc\u00eda R\u00f3denas","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MCP.0000000000000345","article-title":"Role of sputum biomarkers in the management of asthma","volume":"23","author":"Seys","year":"2017","journal-title":"Curr Opin Pulm Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax."},{"key":"10.1016\/j.arbres.2022.01.003_bib1155","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.arbres.2019.08.001","article-title":"Current Role of Biomarkers in Severe Uncontrolled Asthma","volume":"56","author":"Arismendi","year":"2020","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(17)30344-2","article-title":"Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies","volume":"6","author":"FitzGerald","year":"2018","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/pai.13403","article-title":"Blood eosinophil count as predictor of\u00a0asthma\u00a0exacerbation. A meta-analysis","volume":"32","author":"Mallah","year":"2021","journal-title":"Pediatr Allergy Immunol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejim.2018.02.034","article-title":"Association between blood eosinophil count with\u00a0asthma\u00a0hospital readmissions","volume":"53","author":"Gonzalez-Barcala","year":"2018","journal-title":"Eur J Intern Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1175","article-title":"Vitamin D Supplementation: A Treatment With Possible Benefits in Asthma","volume":"S0300\u20132896","author":"And\u00fajar-Espinosa","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1980","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.rmed.2012.07.010","article-title":"Monitoring free serum IgE in severe asthma patients treated with omalizumab","volume":"106","author":"Korn","year":"2012","journal-title":"Respir Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.arbres.2020.03.035","article-title":"FeNO for Asthma Diagnosis in Adults: More Lights Than Shadows","volume":"57","author":"Ojanguren","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/02770903.2018.1545857","article-title":"Dupilumab in patients with uncontrolled asthma: type 2 biomarkers might be predictors of therapeutic efficacy","volume":"57","author":"Yang","year":"2020","journal-title":"J Asthma."},{"key":"10.1016\/j.arbres.2022.01.003_bib1195","article-title":"Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players","volume":"S0300\u20132896","author":"V\u00e1zquez-Mera","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1200","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1038\/s41598-018-20483-1","article-title":"The CD14 (-159 C\/T) SNP is associated with sCD14 levels and allergic\u00a0asthma, but not with CD14 expression on monocytes","volume":"8","author":"Nieto-Fontarigo","year":"2018","journal-title":"Sci Rep."},{"key":"10.1016\/j.arbres.2022.01.003_bib1205","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1038\/s41598-019-43622-8","article-title":"Expansion of different subpopulations of CD26-\/low\u00a0T cells in allergic and non-allergic asthmatics","volume":"9","author":"Nieto-Fontarigo","year":"2019","journal-title":"Sci Rep."},{"key":"10.1016\/j.arbres.2022.01.003_bib1210","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1111\/all.14406","article-title":"iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic\u00a0asthma","volume":"75","author":"Nieto-Fontarigo","year":"2020","journal-title":"Allergy."},{"key":"10.1016\/j.arbres.2022.01.003_bib1215","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.arbr.2020.04.014","article-title":"Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe\u00a0Asthma","volume":"57","author":"Carpagnano","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1220","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/bmm-2019-0414","article-title":"How biomarkers can improve pneumonia diagnosis and prognosis: procalcitonin and mid-regional-pro-adrenomedullin","volume":"14","author":"Spoto","year":"2020","journal-title":"Biomark Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1225","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.medcli.2017.02.024","article-title":"Usefulness and prognostic value of biomarkers in patients with community-acquired pneumonia in the emergency department","volume":"148","author":"Juli\u00e1n-Jim\u00e9nez","year":"2017","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1985","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1378\/chest.125.4.1335","article-title":"Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia","volume":"125","author":"Almirall","year":"2004","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2022.01.003_bib1235","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.11.023","article-title":"Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough","volume":"116","author":"Flanders","year":"2004","journal-title":"Am J Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/cid\/cix317","article-title":"Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia","volume":"65","author":"Self","year":"2017","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.arbres.2022.01.003_bib1245","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/cid\/ciz545","article-title":"Procalcitonin to distinguish viral from bacterial pneumonia: A systematic review and meta-analysis","volume":"70","author":"Kamat","year":"2019","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.arbres.2022.01.003_bib1250","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1750-2659.2012.00386.x","article-title":"Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis","volume":"7","author":"Wu","year":"2013","journal-title":"Influenza Other Respir Viruses."},{"key":"10.1016\/j.arbres.2022.01.003_bib1255","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/thx.2008.110254","article-title":"Biomarkers and community-acquired pneumonia","volume":"64","author":"Brown","year":"2009","journal-title":"Thorax."},{"key":"10.1016\/j.arbres.2022.01.003_bib1260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/23744235.2016.1253860","article-title":"Failure of CRP decline within three days of hospitalization is associated with poor prognosis of Community-acquired Pneumonia","volume":"49","author":"Andersen","year":"2017","journal-title":"Infect Dis (London)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1265","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1378\/chest.128.4.2223","article-title":"Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index","volume":"128","author":"Masi\u00e1","year":"2005","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2022.01.003_bib1270","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1183\/09031936.00054507","article-title":"Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes","volume":"31","author":"Kr\u00fcger","year":"2008","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1275","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/CCM.0b013e3182257445","article-title":"Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia","volume":"39","author":"Ram\u00edrez","year":"2011","journal-title":"Crit Care Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1990","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.chest.2016.04.010","article-title":"Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia","volume":"150","author":"Self","year":"2016","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2022.01.003_bib1285","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjms.2020.05.042","article-title":"Clinical Impact of N-Terminal Prohormone of Brain Natriuretic Peptide on Patients Hospitalized with Community-Acquired Pneumonia","volume":"360","author":"Seo","year":"2020","journal-title":"Am J Med Sci."},{"key":"10.1016\/j.arbres.2022.01.003_bib1290","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/jcm8060843","article-title":"Lymphocytopenia as a Predictor of Mortality in Patients with ICU-Acquired Pneumonia","volume":"8","author":"Ceccato","year":"2019","journal-title":"J Clin Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1295","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.chest.2019.06.040","article-title":"Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers","volume":"156","author":"Men\u00e9ndez","year":"2019","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2022.01.003_bib1300","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.3390\/jcm9113623","article-title":"Troponin Elevation in Older Patients with Acute Pneumonia: Frequency and Prognostic Value","volume":"9","author":"Putot","year":"2020","journal-title":"J Clin Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1305","first-page":"CD007498","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections","volume":"10","author":"Schuetz","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.arbres.2022.01.003_bib1310","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1472-6963-7-102","article-title":"Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial","volume":"7","author":"Schuetz","year":"2007","journal-title":"BMC Health Serv Res."},{"key":"10.1016\/j.arbres.2022.01.003_bib1315","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s15010-021-01615-8","article-title":"C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19","volume":"49","author":"Pink","year":"2021","journal-title":"Infection."},{"key":"10.1016\/j.arbres.2022.01.003_bib1320","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/QCO.0000000000000522","article-title":"Procalcitonin to guide antibiotic decision making","volume":"32","author":"Branche","year":"2019","journal-title":"Curr Opin Infect Dis."},{"key":"10.1016\/j.arbres.2022.01.003_bib1325","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1515\/cclm-2018-0259","article-title":"Procalcitonin-guided antibiotic therapy: an expert consensus","volume":"56","author":"Bartoletti","year":"2018","journal-title":"Clin Chem Lab Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1995","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/cc13760","article-title":"Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis","volume":"18","author":"Pfister","year":"2014","journal-title":"Crit Care."},{"key":"10.1016\/j.arbres.2022.01.003_bib1335","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.CCM.0000297886.32564.CF","article-title":"C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia","volume":"36","author":"Lisboa","year":"2008","journal-title":"Crit Care Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1340","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arbres.2020.07.038","article-title":"The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia","volume":"57","author":"Cill\u00f3niz","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1345","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jinf.2014.12.003","article-title":"Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia","volume":"70","author":"Espa\u00f1a","year":"2015","journal-title":"J Infect."},{"key":"10.1016\/j.arbres.2022.01.003_bib1350","doi-asserted-by":"crossref","first-page":"e0187702","DOI":"10.1371\/journal.pone.0187702","article-title":"Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB","volume":"12","author":"Legramante","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.arbres.2022.01.003_bib1355","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/crj.13062","article-title":"Plasma cytokine profile on admission related to aetiology in community-acquired pneumonia","volume":"13","author":"Burgmeijer","year":"2019","journal-title":"Clin Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1360","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/1817-1737.134072","article-title":"Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia","volume":"9","author":"Andrijevic","year":"2014","journal-title":"Ann Thorac Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1365","doi-asserted-by":"crossref","first-page":"ofz520","DOI":"10.1093\/ofid\/ofz520","article-title":"Host Inflammatory Biomarkers of Disease Severity in Pediatric Community-Acquired Pneumonia: A Systematic Review and Meta-analysis","volume":"6","author":"Fernandes","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"10.1016\/j.arbres.2022.01.003_bib1370","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000504524","article-title":"The Predictive Value of NT-Pro-Brain Natriuretic Peptide for Risk of Pneumonia in Patients on Maintenance Hemodialysis","volume":"49","author":"Guo","year":"2020","journal-title":"Blood Purif."},{"key":"10.1016\/j.arbres.2022.01.003_bib1375","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1183\/09031936.06.00113205","article-title":"High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions","volume":"28","author":"Kolditz","year":"2006","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib2000","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/thx.2009.121178","article-title":"Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ","volume":"65","author":"Kr\u00fcger","year":"2010","journal-title":"Thorax."},{"key":"10.1016\/j.arbres.2022.01.003_bib1385","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12098-018-2607-2","article-title":"New Biomarkers to Diagnose Ventilator Associated Pneumonia: Pentraxin 3 and Surfactant Protein D","volume":"85","author":"Tekerek","year":"2018","journal-title":"Indian J Pediatr."},{"key":"10.1016\/j.arbres.2022.01.003_bib1390","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1186\/s12879-019-4618-7","article-title":"Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions","volume":"19","author":"Song","year":"2019","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.arbres.2022.01.003_bib1395","doi-asserted-by":"crossref","first-page":"1800973","DOI":"10.1183\/13993003.00973-2018","article-title":"Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials","volume":"53","author":"Ebrahimi","year":"2019","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1400","doi-asserted-by":"crossref","first-page":"e0239606","DOI":"10.1371\/journal.pone.0239606","article-title":"Accuracy of C-reactive protein, procalcitonin, serum amyloid A and neopterin for low-dose CT-scan confirmed pneumonia in elderly patients: A prospective cohort study","volume":"15","author":"Prendki","year":"2020","journal-title":"PLoS One."},{"key":"10.1016\/j.arbres.2022.01.003_bib1405","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/jcph.1914","article-title":"Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial","volume":"61","author":"Raess","year":"2021","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1410","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/00365513.2017.1344298","article-title":"Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia","volume":"77","author":"Kim","year":"2017","journal-title":"Scand J Clin Lab Invest."},{"key":"10.1016\/j.arbres.2022.01.003_bib1415","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.ajem.2018.03.050","article-title":"Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED","volume":"36","author":"Zhou","year":"2018","journal-title":"Am J Emerg Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1420","doi-asserted-by":"crossref","first-page":"e0248897","DOI":"10.1371\/journal.pone.0248897","article-title":"Developing the Pneumonia-Optimized Ratio for Community-acquired pneumonia: An easy, inexpensive and accurate prognostic biomarker","volume":"16","author":"Cury","year":"2021","journal-title":"PLoS One."},{"key":"10.1016\/j.arbres.2022.01.003_bib1425","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/joim.12341","article-title":"Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study","volume":"278","author":"Alan","year":"2015","journal-title":"J Intern Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib2005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.arbres.2019.02.024","article-title":"Bronchiectasis: A Complex Heterogeneous Disease","volume":"55","author":"Mart\u00ednez-Garc\u00eda","year":"2019","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1435","doi-asserted-by":"crossref","first-page":"1701655","DOI":"10.1183\/13993003.01655-2017","article-title":"Precision medicine in airway diseases: moving to clinical practice","volume":"50","author":"Agust\u00ed","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1440","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/thorax.56.5.366","article-title":"Assessment of airway neutrophils by sputum colour: correlation with airways inflammation","volume":"56","author":"Stockley","year":"2001","journal-title":"Thorax."},{"key":"10.1016\/j.arbres.2022.01.003_bib1445","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.3390\/ijms22095018","article-title":"Proteases Mucus, and Mucosal Immunity in Chronic Lung Disease","volume":"22","author":"McKelvey","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.arbres.2022.01.003_bib1450","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1455","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1460","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1164\/rccm.201809-1651OC","article-title":"Airway bacterial load and inhaled antibiotic response in bronchiectasis","author":"Sibila","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1465","doi-asserted-by":"crossref","first-page":"1602086","DOI":"10.1183\/13993003.02086-2016","article-title":"The microbiome in respiratory medicine: Current challenges and future perspectives","volume":"49","author":"Faner","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1470","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.arbres.2019.12.017","article-title":"C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations Data From the Spanish Registry of Bronchiectasis (RIBRON)","volume":"57","author":"Posadas","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1475","doi-asserted-by":"crossref","first-page":"L681","DOI":"10.1152\/ajplung.00014.2014","article-title":"Molecular biomarkers in idiopathic pulmonary fibrosis","volume":"307","author":"Ley","year":"2014","journal-title":"Am J Physiol Cell Mol Physiol."},{"key":"10.1016\/j.arbres.2022.01.003_bib2010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.arbres.2019.08.002","article-title":"Biomarcadores s\u00e9ricos en las enfermedades pulmonares intersticiales difusas","volume":"56","author":"Sellar\u00e9s","year":"2020","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1485","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MCP.0000000000000187","article-title":"Personalized medicine in idiopathic pulmonary fibrosis: facts and promises","volume":"21","author":"Spagnolo","year":"2015","journal-title":"Curr Opin Pulm Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1490","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.chest.2018.12.011","article-title":"Integrating genomics into management of fibrotic interstitial lung disease","volume":"155","author":"Adegunsoye","year":"2019","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2022.01.003_bib1495","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.arbres.2019.08.020","article-title":"Clinical Research on Prognostic Evaluation of Subjects With IPF by Peripheral Blood Biomarkers Quantitative Imaging Characteristics and Pulmonary Function Parameters","volume":"56","author":"Guo","year":"2020","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1500","first-page":"00116","article-title":"Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity","volume":"S0300\u20132896","author":"Bermudo","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1505","first-page":"00112","article-title":"Study of Diffuse Interstitial Lung Disease With the Analysis of Volatile Particles in Exhaled Air","volume":"S0300\u20132896","author":"Castillo Villegas","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1510","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.arbres.2019.07.001","article-title":"A Multidisciplinary Proposal for a Diagnostic Algorithm in Idiopathic Pulmonary Fibrosis: The Role of Transbronchial Cryobiopsy","volume":"56","author":"Castillo","year":"2020","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1515","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.arbres.2019.05.008","article-title":"The Future of Pharmacological Treatment in Idiopathic Pulmonary Fibrosis","volume":"55","author":"Molina-Molina","year":"2019","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1520","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.arbr.2021.03.009","article-title":"Detection of Autoantibodies in Bronchoalveolar Lavage in Patients with Diffuse Interstitial Lung Disease","volume":"57","author":"Salvador-Corres","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1525","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.arbres.2020.08.005","article-title":"Pro-fibrotic Factors as Potential Biomarkers of Anti-fibrotic Drug Therapy in Patients With Idiopathic Pulmonary Fibrosis","volume":"57","author":"Lopez-Lopez","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1530","doi-asserted-by":"crossref","first-page":"1901647","DOI":"10.1183\/13993003.01647-2019","volume":"54","author":"Konstantinides","year":"2019","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1535","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1538-7836.2010.03801.x","article-title":"Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis","volume":"8","author":"Ceriani","year":"2010","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.arbres.2022.01.003_bib1540","first-page":"00056","article-title":"Multidisciplinary Consensus for the Management of Pulmonary Thromboembolism","volume":"S0300\u20132896","author":"Lobo","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1545","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1160\/TH-08-10-0689","article-title":"VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies","volume":"101","author":"Carrier","year":"2009","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.arbres.2022.01.003_bib1550","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.2014.2135","article-title":"Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study","volume":"311","author":"Righini","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.arbres.2022.01.003_bib1555","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","article-title":"Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model","volume":"121","author":"Eichinger","year":"2010","journal-title":"Circulation."},{"key":"10.1016\/j.arbres.2022.01.003_bib1560","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","article-title":"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)","volume":"10","author":"Tosetto","year":"2012","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.arbres.2022.01.003_bib1565","doi-asserted-by":"crossref","first-page":"j1065","DOI":"10.1136\/bmj.j1065","article-title":"Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study","volume":"356","author":"Rodger","year":"2017","journal-title":"BMJ."},{"key":"10.1016\/j.arbres.2022.01.003_bib1570","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.arbr.2020.10.008","article-title":"Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer","volume":"56","author":"Rodriguez-Sevilla","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1580","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.hrtlng.2015.03.007","article-title":"Prognostic value of troponins in acute nonmassive pulmonary embolism: A meta-analysis","volume":"44","author":"Bajaj","year":"2015","journal-title":"Heart Lung."},{"key":"10.1016\/j.arbres.2022.01.003_bib1585","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1183\/09031936.00174514","article-title":"Age-adjusted high-sensitivity troponin T cut-off value for risk stratification of pulmonary embolism","volume":"45","author":"Kaeberich","year":"2015","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1590","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.106.680421","article-title":"Prognostic value of troponins in acute pulmonary embolism: a meta-analysis","volume":"116","author":"Becattini","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.arbres.2022.01.003_bib1595","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2009.10.078","article-title":"Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism","volume":"55","author":"Dellas","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1600","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1161\/01.CIR.0000064898.51892.09","article-title":"Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism","volume":"107","author":"Kucher","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.arbres.2022.01.003_bib1605","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1164\/rccm.200803-459OC","article-title":"Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis","volume":"178","author":"Klok","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1610","doi-asserted-by":"crossref","first-page":"1702037","DOI":"10.1183\/13993003.02037-2017","article-title":"Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study","volume":"51","author":"Hellenkamp","year":"2018","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1615","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/CCM.0b013e318192fd9d","article-title":"A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis","volume":"37","author":"Shapiro","year":"2009","journal-title":"Crit Care Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1620","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0038-1676522","article-title":"The Prognostic Value of Renal Function in Acute Pulmonary Embolism-A Multi-Centre Cohort Study","volume":"119","author":"Kostrubiec","year":"2019","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.arbres.2022.01.003_bib1625","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijcard.2016.11.120","article-title":"Hyponatremia and short-term prognosis of patients with acute pulmonary embolism: A meta-analysis","volume":"227","author":"Zhou","year":"2017","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1630","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/heartjnl-2012-301884","article-title":"Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism","volume":"98","author":"Kostrubiec","year":"2012","journal-title":"Heart."},{"key":"10.1016\/j.arbres.2022.01.003_bib1635","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.thromres.2017.08.021","article-title":"Risk factors of occult malignancy in patients with unprovoked venous thromboembolism","volume":"159","author":"Robin","year":"2017","journal-title":"Thromb Res."},{"key":"10.1016\/j.arbres.2022.01.003_bib1640","doi-asserted-by":"crossref","first-page":"e0153514","DOI":"10.1371\/journal.pone.0153514","article-title":"Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.arbres.2022.01.003_bib1645","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/jth.13842","article-title":"Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score","volume":"15","author":"Bertoletti","year":"2017","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.arbres.2022.01.003_bib1650","doi-asserted-by":"crossref","first-page":"e0194673","DOI":"10.1371\/journal.pone.0194673","article-title":"Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism","volume":"13","author":"Jara-Palomares","year":"2018","journal-title":"PLoS One."},{"key":"10.1016\/j.arbres.2022.01.003_bib1655","first-page":"105","article-title":"Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters","volume":"23","author":"Marchena Yglesias","year":"2006","journal-title":"An Med Interna."},{"key":"10.1016\/j.arbres.2022.01.003_bib1660","doi-asserted-by":"crossref","first-page":"4","DOI":"10.23736\/S0392-9590.17.03848-2","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis","volume":"37","author":"Wang","year":"2018","journal-title":"Int Angiol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1665","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/crj.12565","article-title":"Relation between lymphocyte to monocyte ratio and short-term mortality in patients with acute pulmonary embolism","volume":"12","author":"Ertem","year":"2018","journal-title":"Clin Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1670","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1164\/rccm.200712-1786OC","article-title":"Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism","volume":"177","author":"Lankeit","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1675","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jacc.2011.06.006","article-title":"Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial","volume":"58","author":"Maisel","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1680","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11239-014-1131-0","article-title":"A panel of microRNAs as a new biomarkers for the detection of deep vein thrombosis","volume":"39","author":"Qin","year":"2015","journal-title":"J Thromb Thrombolysis."},{"key":"10.1016\/j.arbres.2022.01.003_bib1685","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1479-5876-9-159","article-title":"MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism","volume":"9","author":"Xiao","year":"2011","journal-title":"J Transl Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1690","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.thromres.2015.12.006","article-title":"MiR-28-3p as a potential plasma marker in diagnosis of pulmonary embolism","volume":"138","author":"Zhou","year":"2016","journal-title":"Thromb Res."},{"key":"10.1016\/j.arbres.2022.01.003_bib1695","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1126\/science.aaz3834","article-title":"Are noncommunicable diseases communicable?","volume":"367","author":"Finlay","year":"2020","journal-title":"Science."},{"key":"10.1016\/j.arbres.2022.01.003_bib1700","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1705","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.recesp.2016.12.029","article-title":"Trends in Pulmonary Hypertension Over a Period of 30 Years: Experience From a Single Referral Centre","volume":"70","author":"Quezada Loaiza","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1710","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cll.2013.11.007","article-title":"Natriuretic peptides in heart failure and acute coronary syndrome","volume":"34","author":"Gaggin","year":"2014","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.arbres.2022.01.003_bib1715","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1183\/09031936.00160307","article-title":"Biomarkers in pulmonary hypertension","volume":"32","author":"Warwick","year":"2008","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1720","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1183\/09031936.05.00100504","article-title":"N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension","volume":"25","author":"Souza","year":"2005","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1725","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.healun.2014.12.005","article-title":"Circulating biomarkers in pulmonary arterial hypertension: update and future direction","volume":"34","author":"Pezzuto","year":"2015","journal-title":"J Heart Lung Transplant."},{"key":"10.1016\/j.arbres.2022.01.003_bib1730","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","article-title":"Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension","volume":"122","author":"Soon","year":"2010","journal-title":"Circulation."},{"key":"10.1016\/j.arbres.2022.01.003_bib1735","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.arbr.2019.12.013","article-title":"Gas Exchange and Ventilatory Efficiency During Exercise in Pulmonary Vascular Diseases","volume":"56","author":"Weatherald","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1740","doi-asserted-by":"crossref","first-page":"220","DOI":"10.21037\/tlcr.2018.05.06","article-title":"The epidemiology of lung cancer","volume":"7","author":"de Groot","year":"2018","journal-title":"Transl Lung Cancer Res."},{"key":"10.1016\/j.arbres.2022.01.003_bib1745","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.arbr.2020.07.016","article-title":"Preoperative Body Weight and Albumin Predict Survival in Patients With Resectable Lung Neoplasms: Role of COPD","volume":"57","author":"Tang","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1750","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12032-009-9217-9","article-title":"Platelet\u00a0count: association with prognosis in lung cancer","volume":"27","author":"Gonzalez Barcala","year":"2010","journal-title":"Med Oncol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1755","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.arbr.2020.06.014","article-title":"Osimertinib for the Treatment of EGFR Mutation-Positive Lung Adenocarcinoma Complicated With Dermatomyositis","volume":"56","author":"Yamasaki","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1760","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.arbres.2020.01.020","article-title":"Microbioma de la v\u00eda a\u00e9rea inferior y c\u00e1ncer de pulm\u00f3n","volume":"56","author":"Garc\u00eda-Pach\u00f3n","year":"2020","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1765","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.arbr.2019.04.018","article-title":"Lung Cancer and Microbiome","volume":"56","author":"Garrido-Mart\u00edn","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1770","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.lungcan.2021.02.026","article-title":"The evolving landscape of biomarker testing for non-small cell lung cancer in Europe","volume":"154","author":"Kerr","year":"2021","journal-title":"Lung Cancer."},{"key":"10.1016\/j.arbres.2022.01.003_bib1775","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.arbr.2020.01.013","article-title":"Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma","volume":"57","author":"Taus","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1780","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1158\/1055-9965.EPI-20-0865","article-title":"Biomarkers for Lung Cancer Screening and Detection","volume":"29","author":"Ostrin","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/j.arbres.2022.01.003_bib1785","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1940-6207.CAPR-10-0328","article-title":"EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer","volume":"4","author":"Lam","year":"2011","journal-title":"Cancer Prev Res (Phila)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1790","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jtho.2016.08.143","article-title":"Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer","volume":"12","author":"Massion","year":"2017","journal-title":"J Thorac Oncol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1795","doi-asserted-by":"crossref","first-page":"e0197826","DOI":"10.1371\/journal.pone.0197826","article-title":"Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules","volume":"13","author":"Edelsberg","year":"2018","journal-title":"PLoS One."},{"key":"10.1016\/j.arbres.2022.01.003_bib1800","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s13277-012-0379-2","article-title":"EarlyCDT\u00ae-Lung test: improved clinical utility through additional autoantibody assays","volume":"33","author":"Chapman","year":"2012","journal-title":"Tumour Biol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1805","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2013.10.008","article-title":"Audit of the autoantibody testEarlyCDT\u00ae-lung, in 1600 patients: an evaluation of its performance in routine clinical practice","volume":"83","author":"Jett","year":"2014","journal-title":"Lung Cancer."},{"key":"10.1016\/j.arbres.2022.01.003_bib1810","first-page":"2000670","article-title":"Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging","volume":"57","author":"Sullivan","year":"2021","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1815","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.chest.2018.02.012","article-title":"Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial","volume":"154","author":"Silvestri","year":"2018","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2022.01.003_bib1820","first-page":"1283","article-title":"Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial","volume":"101","author":"Tanner","year":"2020","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2022.01.003_bib1825","doi-asserted-by":"crossref","first-page":"e0134376","DOI":"10.1371\/journal.pone.0134376","article-title":"Diagnostic accuracy of natriuretic peptides for heart failure in patients with pleural effusion: a systematic review and updated meta-analysis","volume":"10","author":"Han","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.arbres.2022.01.003_bib1830","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1183\/09031936.00197208","article-title":"Biomarkers of infection for the differential diagnosis of pleural effusions","volume":"34","author":"Porcel","year":"2009","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1835","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.arbres.2018.05.007","article-title":"Diagnostic Accuracy of Pleural Fluid Adenosine Deaminase for Diagnosing Tuberculosis Meta-analysis of Spanish Studies","volume":"55","author":"Palma","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.01.003_bib1840","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1038\/s41598-020-62388-y","article-title":"Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial","volume":"10","author":"Botana-Rial","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.arbres.2022.01.003_bib1845","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/1759-7714.12932","article-title":"Detecting EGFR mutations and ALK\/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples","volume":"10","author":"Yao","year":"2019","journal-title":"Thorac Cancer."},{"key":"10.1016\/j.arbres.2022.01.003_bib1850","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/smrv.2000.0120","article-title":"The genetics of sleep apnea","volume":"4","author":"Redline","year":"2000","journal-title":"Sleep Med Rev."},{"key":"10.1016\/j.arbres.2022.01.003_bib1855","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/NSS.S164488","article-title":"Use of blood biomarkers to screen for obstructive sleep apnea","volume":"10","author":"Fleming","year":"2018","journal-title":"Nat Sci Sleep."},{"key":"10.1016\/j.arbres.2022.01.003_bib1860","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.smrv.2014.11.004","article-title":"Biomarkers associated with obstructive sleep apnea: A scoping review","volume":"23","author":"Canto","year":"2015","journal-title":"Sleep Med Rev."},{"key":"10.1016\/j.arbres.2022.01.003_bib1865","doi-asserted-by":"crossref","first-page":"e0213622","DOI":"10.1371\/journal.pone.0213622","article-title":"Identification and validation of circulating miRNAs as endogenous controls in obstructive sleep apnea","volume":"14","author":"Santamar\u00eda-Martos","year":"2019","journal-title":"PLoS ONE."},{"key":"10.1016\/j.arbres.2022.01.003_bib1870","doi-asserted-by":"crossref","first-page":"13456","DOI":"10.1038\/s41598-019-49940-1","article-title":"Circulating microRNA profile as a potential biomarker for obstructive sleep apnea diagnosis","volume":"9","author":"Santamar\u00eda-Martos","year":"2019","journal-title":"Sci Rep."},{"key":"10.1016\/j.arbres.2022.01.003_bib1875","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jacc.2015.06.1315","article-title":"Precision Medicine in Patients With Resistant Hypertension and Obstructive Sleep Apnea: Blood Pressure Response to Continuous Positive Airway Pressure Treatment","volume":"66","author":"S\u00e1nchez-de-la-Torre M.","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1880","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.200905-0765OC","article-title":"Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea","volume":"180","author":"Gozal","year":"2009","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1885","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1378\/chest.12-2606","article-title":"Urinary neurotransmitters are selectively altered in children with obstructive sleep apnea and predict cognitive morbidity","volume":"143","author":"Kheirandish-Gozal","year":"2013","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2022.01.003_bib1890","first-page":"243","article-title":"The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea","volume":"8","author":"Bisogni","year":"2016","journal-title":"J Thorac Dis."},{"key":"10.1016\/j.arbres.2022.01.003_bib1895","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1164\/ajrccm.165.7.2104126","article-title":"Increased adhesion molecules expression and production of reactive oxygens pecies in leukocytes of sleep apnea patients","volume":"165","author":"Dyugovskaya","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1900","article-title":"Procoagulant State of Sleep Apnea Depends on Systemic Inflammation and Endothelial Damage","author":"Fern\u00e1ndez-Bello","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1905","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/sleep\/18.3.188","article-title":"Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients","volume":"18","author":"R\u00e5ngemark","year":"1995","journal-title":"Sleep."},{"key":"10.1016\/j.arbres.2022.01.003_bib1910","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1378\/chest.124.4.1386","article-title":"8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy","volume":"124","author":"Carpagnano","year":"2003","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2022.01.003_bib1915","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1034\/j.1399-3003.2000.16d13.x","article-title":"Abnormal lipid peroxidation in patients with sleep apnoea","volume":"16","author":"Barcel\u00f3","year":"2000","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1920","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11325-006-0074-x","article-title":"Evidence for activation of nuclear factor kappaB in obstructive sleep apnoea","volume":"10","author":"Yamauchi","year":"2006","journal-title":"Sleep Breath."},{"key":"10.1016\/j.arbres.2022.01.003_bib1925","doi-asserted-by":"crossref","first-page":"1701885","DOI":"10.1183\/13993003.01885-2017","article-title":"Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea","volume":"51","author":"Santamaria-Martos","year":"2018","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1930","doi-asserted-by":"crossref","first-page":"1801298","DOI":"10.1183\/13993003.01298-2018","article-title":"Soluble PD-L1 is a potential biomarker of cutaneous melanoma aggressiveness and metastasis in obstructive sleep apnoea patients","volume":"53","author":"Cubillos-Zapata","year":"2019","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2022.01.003_bib1935","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccm.2004.05.009","article-title":"Interstitial lung disease in the patient who has connective tissue diseae","volume":"25","author":"Strange","year":"2004","journal-title":"Clin Chest Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1940","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40291-014-0109-0","article-title":"Molecular biomarkers in interstitial lung diseases","volume":"18","author":"De Lauretis","year":"2014","journal-title":"Mol Diagn Ther."},{"key":"10.1016\/j.arbres.2022.01.003_bib1945","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2022.01.003_bib1950","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2019.03.033","article-title":"Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review","volume":"702","author":"Karami","year":"2019","journal-title":"Gene."},{"issue":"S0300\u20132896","key":"10.1016\/j.arbres.2022.01.003_bib1955","first-page":"30129","article-title":"Prevalence and Clinical Impact of Systemic Autoimmune Rheumatic Disease in Patients with Silicosis","author":"Blanco P\u00e9rez","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)."},{"key":"10.1016\/j.arbres.2022.01.003_bib1960","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccm.2019.05.004","article-title":"Interstitial Lung Disease in Polymyositis and Dermatomyositis","volume":"40","author":"Long","year":"2019","journal-title":"Clin Chest Med."},{"key":"10.1016\/j.arbres.2022.01.003_bib1965","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.40815","article-title":"Performance of candidate serum biomarkers for systemic sclerosis-interstitial lung disease","volume":"71","author":"Elhai","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.arbres.2022.01.003_bib1970","first-page":"1112","article-title":"Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis","volume":"31","author":"Yanaba","year":"2004","journal-title":"J Rheumatol."}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289622000151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289622000151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:42:18Z","timestamp":1759531338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289622000151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":197,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0300289622000151"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2022.01.003","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarcadores biol\u00f3gicos en las enfermedades respiratorias","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}